# Indrayani Hospital and Cancer Institute – FDA Inspection, Aug 11, 2023

Source: https://www.keypedia.com/records/fda_inspections/indrayani-hospital-and-cancer-institute/3cd4ddfb-d75d-481c-a1b9-d8f59ea3abf1
Source feed: FDA_Inspections

> FDA inspection 1216544 of Indrayani Hospital and Cancer Institute, August 11, 2023. Classification: Official Action Indicated (OAI). Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1216544
- Company Name: Indrayani Hospital and Cancer Institute
- Inspection Date: 2023-08-11
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)
- [FDA Associated Person](https://www.keypedia.com/people/lori-gioia/34b9339b-0bd2-4e41-8da1-b445ad829e53)

Company: https://www.keypedia.com/companies/indrayani-hospital-and-cancer-institute/55f1e280-716d-47e5-a651-1a14fae38104

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
